High-value biologic therapies are overtaking traditional treatments, driving revenue despite pricing pressures on standard ...

Please provide your email address to receive an email when new articles are posted on . To overcome barriers to biologic care for patients with asthma, personalized treatment is key, according to a ...

Two posters presented at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting evaluated real-world biologic utilization for patients with severe, uncontrolled asthma.

Verekitug provided statistically significant and clinically meaningful reductions in annualized asthma exacerbation rate (AAER) with 100 mg q12 ...

A new study has found that using biologic therapy to reduce lung inflammation enabled 92% of people with severe asthma to reduce their dose of daily inhaled steroid without exacerbating their symptoms ...

Improvement across all asthma control parameters was achieved after 12 months of biologic treatment, according to one study. Patients with severe asthma treated with either omalizumab, benralizumab, ...

7 asthma medications: A guide to learn more Asthma is a chronic respiratory condition that affects millions of people of all ages. While there is no cure, modern asthma medications make it possible ...

Adults with severe asthma who had poor inhaled corticosteroid/long-acting beta agonist adherence in their first year of tezepelumab did not differ from those with better adherence in several clinical ...

Asthma causes inflammation and narrowing of the airways, making it harder to breathe. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath. These symptoms can vary in ...